Areva apparently looks to
sell a 15% equity stake for $3-4bn in order to (
partially) fund its investment plans. Not a good sign for nuclear, as Areva was considered to be one of the strongest players (although perhaps it's partly a cash flow issue inherent to such a capital-intensive business).
No comments:
Post a Comment